|
enacyloxin |
31 |
0.5 |
0.49 |
0.63 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CC/C=C/[C@@H](OC(N)=O)[C@@H](Cl)[C@H](O)CC(=O)C(O)C(O)[C@H](C)/C(Cl)=C/C=C/C=C(C)/C=C/C=C/C(=O)O[C@@H]1C[C@@H](C(=O)O)CC[C@@H]1O |
view |
enacyloxin |
|
|
heronamide A |
32 |
0.5 |
0.51 |
0.62 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CCC/C=C/C=C/C[C@@H]1C[C@H](O)C2[C@@H]3/C(C)=C\[C@@H]4C=C[C@H](O)[C@H](O)[C@H]4/C(C)=C\C=C/[C@H]3C(=O)N21 |
view |
heronamide A |
|
|
Thuggacin A |
33 |
0.5 |
0.53 |
0.61 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
C/C=C(C)/C=C(\C)C(O)C(C)[C@@H](O)[C@H](O)[C@@H]1C/C=C\C=C/[C@@H](O)C[C@H](O)[C@@H](C)c2nc(cs2)/C=C(/CCCCCC)C(=O)O1 |
view |
Thuggacin A |
|
|
naphthomycin |
34 |
0.49 |
0.48 |
0.62 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
C/C1=C/C[C@H](O)/C=C\[C@H](C)[C@H](O)[C@@H](C)/C=C(/C)C(=O)c2c(O)c(C)cc3c2C(=O)C(Cl)=C(NC(=O)/C(C)=C\C=C/C=C\[C@H](C)[C@@H](O)CC1=O)C3=O |
view |
naphthomycin |
|
|
Aurafuron A |
35 |
0.48 |
0.49 |
0.6 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CC1=C(CC(O)/C=C\C=C\C(C)C(O)/C(C)=C/CC(C)C)OC(C)(O)C1=O |
view |
Aurafuron A |
|
|
chaxamycin C |
13 |
0.55 |
0.49 |
0.74 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CC1=C2NC(=O)/C=C\C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](CO)/C=C(/C)C(=O)c3c(O)c(C)c(O)c(c3C1=O)C2=O |
view |
chaxamycin C |
|
|
tirucalla |
14 |
0.55 |
0.47 |
0.74 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CC(C)=CCC[C@H](C)[C@@H]1CC[C@]2(C)C3=CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C |
view |
tirucalla |
|
|
chaxamycin B |
15 |
0.55 |
0.5 |
0.73 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CC1=C2NC(=O)/C=C\C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C(/C)C(=O)c3c(O)c(C)cc(c3C1=O)C2=O |
view |
chaxamycin B |
|
|
E-975 |
16 |
0.55 |
0.53 |
0.7 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CC/C=C(\C)C(O)C(C)/C=C/C=C/CCC(O)CC1=C(C)C(=O)C(O)(C(C)O)O1 |
view |
E-975 |
|
|
heronamide E |
17 |
0.54 |
0.48 |
0.72 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
C/C=C/C=C/C[C@@H]1C[C@@H]2/C=C\C(C)=C/[C@H]3C=C[C@@H](O)[C@@H](O)[C@@H]3/C(C)=C\C=C/[C@H]2C(=O)N1 |
view |
heronamide E |
|
|
pladienolide |
18 |
0.54 |
0.5 |
0.71 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CC[C@H](O)[C@@H](C)[C@H]1O[C@H]1C[C@H](C)/C=C/C=C(\C)[C@H]1OC(=O)C[C@@H](O)CC[C@@](C)(O)[C@@H](OC(C)=O)/C=C\[C@@H]1C |
view |
pladienolide |
|
|
Dawenol |
19 |
0.54 |
0.53 |
0.69 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
C/C=C\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C(C)=C\C(C)C(O)C(C)C(C)OC(C)=O |
view |
Dawenol |
|
|
macrobrevin |
20 |
0.54 |
0.54 |
0.67 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CCC(C)C(O)/C=C/C(C)=C/C=C/C(C)CC(C)C1CC(O)C(C)/C=C\C=C/C(C)C/C=C(/C)C(O)/C=C\CC(O)C(C)/C=C\C(=O)O1 |
view |
macrobrevin |
|
|
alpha-lipomycin |
21 |
0.54 |
0.52 |
0.59 |
0.4 |
Glyco:1/3 * 6-Ring:0/1 |
MIBiG |
Source |
CC(/C=C/C=C/C=C/C=C/C(=O)C1=C(O)C(CCC(=O)O)N(C)C1=O)=C\C(C)C(O[C@H]1C[C@H](O)[C@H](O)[C@@H](C)O1)C(C)C |
view |
alpha-lipomycin |
|
|
E-492 |
22 |
0.53 |
0.51 |
0.68 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
C/C=C(\C)C(O)C(C)/C=C/C=C/CCC(O)CC1=C(C)C(=O)C(O)(C(C)O)O1 |
view |
E-492 |
|
|
Etnangien |
23 |
0.52 |
0.5 |
0.66 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
COC1C(C)C(O)CC(=O)OC(C(C)C(O)/C=C(C)/C=C/C=C/C=C/C=C/C=C/CC(O)/C=C(\C)CCC(=O)O)CC(O)CCCC(O)C/C=C\C=C/CC(C)C(O)C1C |
view |
Etnangien |
|
|
heronamide B |
24 |
0.52 |
0.5 |
0.66 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CCC/C=C/C=C/C[C@@H]1C[C@@H]2/C=C\C(C)=C/[C@@H]3C=C[C@H](O)[C@H](O)[C@H]3/C(C)=C\C=C/[C@H]2C(=O)N1 |
view |
heronamide B |
|
|
Elansolid A1 |
25 |
0.52 |
0.54 |
0.64 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
COC(c1ccc(O)cc1)C1C(/C=C\C=C\C=C/C(O)C(C)C(O)C/C=C(C)/C=C/C(=O)O)C(C)=CC2C1C(C)(C)C[C@]2(C)O |
view |
Elansolid A1 |
|
|
halstoctacosanolide |
26 |
0.52 |
0.48 |
0.58 |
0.4 |
Glyco:0/3 * 6-Ring:1/1 |
MIBiG |
Source |
CCC(O)C(C)C(O)CC(O)C(O)/C=C(\C)CC(C)C1CC(O)C(C)/C=C\C=C/CC(C)C(=O)CC2CCC(C)C(O)(C/C=C(C)\C=C(\C)C(O)C(=O)/C=C(/C)C(=O)O1)O2 |
view |
halstoctacosanolide |
|
|
heronamide D |
27 |
0.51 |
0.49 |
0.66 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
C/C=C/C=C/CC1C[C@H](O)C2C3/C(C)=C\C4C=C[C@@H](O)[C@@H](O)C4/C(C)=C\C=C/C3C(=O)N12 |
view |
heronamide D |
|
|
heronamide C |
28 |
0.51 |
0.49 |
0.66 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CCC/C=C\C=C/C[C@H]1C/C=C\C=C(C)/C=C\C=C/[C@H](O)[C@H](O)/C=C(C)\C=C/C=C\C(=O)N1 |
view |
heronamide C |
|
|
filipin |
29 |
0.51 |
0.5 |
0.64 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CCCCC[C@@H](O)[C@H]1C(=O)O[C@H](C)[C@@H](O)/C=C\C=C/C=C\C=C/C=C(/C)[C@@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O |
view |
filipin |
|
|
E-837 |
30 |
0.5 |
0.49 |
0.63 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
C/C=C(\C)C(O)C(C)/C=C/C=C(\C)CCC(O)CC1=C(C)C(=O)C(C)(O)O1 |
view |
E-837 |
|
|
BE-14106 |
36 |
0.48 |
0.49 |
0.6 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CCC/C=C/CC1C/C=C\C=C(C)/C=C\C=C/C(O)C(O)/C=C(C)\C=C/C=C\C(=O)N1 |
view |
BE-14106 |
|
|
Bafilomycin B1 |
0 |
0.64 |
0.51 |
0.8 |
0.4 |
Glyco:0/3 * 6-Ring:1/1 |
MIBiG |
Source |
CO/C1=C/C(C)=C\[C@@H](C)[C@@H](O)[C@H](C)C/C(C)=C\C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@@H](C(C)C)O2)OC1=O |
view |
Bafilomycin B1 |
|
|
JBIR-100 |
1 |
0.64 |
0.51 |
0.79 |
0.4 |
Glyco:0/3 * 6-Ring:1/1 |
MIBiG |
Source |
C/C1=C/C(C)C(O)C(C)C/C(C)=C\C=C/CC(C(C)C(O)C(C)C2(O)CC(OC(=O)/C=C/C(=O)O)C(C)C(C(C)C)O2)OC(=O)\C(C)=C/1 |
view |
JBIR-100 |
|
|
nemadectin |
2 |
0.63 |
0.48 |
0.81 |
0.33 |
Glyco:0/3 * 6-Ring:2/1 |
MIBiG |
Source |
CC1=C[C@H]2C(=O)O[C@H]3C[C@@H](C/C=C(/C)C[C@@H](C)/C=C\C=C4\CO[C@H]([C@@H]1O)[C@@]42O)OC1(C3)C[C@H](O)[C@H](C)[C@@H](/C(C)=C/C(C)C)O1 |
view |
nemadectin |
|
|
concanamycin A |
3 |
0.63 |
0.52 |
0.77 |
0.4 |
Glyco:0/3 * 6-Ring:1/1 |
MIBiG |
Source |
C/C=C/[C@H]1O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C(OC)=C\C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C\C=C/[C@@H]2OC)C[C@@H](O)[C@@H]1C |
view |
concanamycin A |
|
|
FD-891 |
4 |
0.6 |
0.57 |
0.78 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CO[C@@H](C)[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)CCC(C)[C@@H]1C/C=C\C=C/CC(O)C2O[C@H]2[C@@H](O)[C@H](C)/C=C(C)\C=C(\C)C(=O)O1 |
view |
FD-891 |
|
|
Kendomycin |
5 |
0.6 |
0.48 |
0.73 |
0.4 |
Glyco:0/3 * 6-Ring:1/1 |
MIBiG |
Source |
CC1=C2O[C@]3(O)C=C2C(=C(O)C1=O)[C@@H]1O[C@H](CC[C@H](C)/C=C(/C)C[C@@H](C)C[C@@H]3C)[C@H](C)[C@H](O)[C@H]1C |
view |
Kendomycin |
|
|
ambruticin |
6 |
0.6 |
0.5 |
0.72 |
0.4 |
Glyco:0/3 * 6-Ring:1/1 |
MIBiG |
Source |
CC[C@H]1O[C@@H](/C(C)=C/[C@H](C)/C=C/[C@@H]2[C@@H](/C=C/[C@@H]3O[C@H](CC(=O)O)C[C@H](O)[C@H]3O)[C@@H]2C)CC=C1C |
view |
ambruticin |
|
|
Spirangien A1 |
7 |
0.58 |
0.48 |
0.72 |
0.33 |
Glyco:0/3 * 6-Ring:2/1 |
MIBiG |
Source |
C/C=C(\C)C[C@H](C)[C@H](O)[C@@H](C)[C@H]1O[C@@]2(C[C@@H](OC)[C@H]1C)O[C@H]([C@@H](C)[C@@H](O)[C@@H](C)/C=C\C=C\C=C/C=C/C=C\[C@H](CC(=O)O)OC)[C@@H](C)C[C@@H]2O |
view |
Spirangien A1 |
|
|
reveromycin |
8 |
0.57 |
0.5 |
0.69 |
0.33 |
Glyco:0/3 * 6-Ring:2/1 |
MIBiG |
Source |
CCCC[C@@]1(OC(=O)CCC(=O)O)CC[C@]2(CC[C@H](C)[C@@H](C/C=C(C)/C=C/[C@H](O)C(C)/C=C/C(=O)O)O2)O[C@H]1/C=C/C(C)=C/C(=O)O |
view |
reveromycin |
|
|
Thalianol |
9 |
0.56 |
0.47 |
0.76 |
0.0 |
Glyco:0/3 * 6-Ring:0/1 |
MIBiG |
Source |
CC(C)=CCC/C(C)=C/CC[C@@H](C)[C@@]1(C)CCC2=C1CC[C@H]1C(C)(C)[C@@H](O)CC[C@]21C |
view |
Thalianol |
|
|
macrolactin 1b |
10 |
0.56 |
0.47 |
0.67 |
0.4 |
Glyco:1/3 * 6-Ring:0/1 |
MIBiG |
Source |
C[C@@H]1CCC/C=C\C=C/[C@H](O)C[C@@H](O)C/C=C\C=C/[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C/C=C\C=C/C(=O)O1 |
view |
macrolactin 1b |
|
|
meridamycin |
11 |
0.56 |
0.49 |
0.65 |
0.4 |
Glyco:0/3 * 6-Ring:1/1 |
MIBiG |
Source |
CC/C1=C/C[C@@H](/C(C)=C/[C@@H](C)[C@@H](C)O)OC(=O)C2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](O)[C@H](C)[C@@H](O)C[C@@H](O)C[C@H](O)/C(C)=C\[C@@H](C)CC(C)[C@@H]1O |
view |
meridamycin |
|